• L-Phenylephrine: Optimizing Adrenergic α1A Agonist Workflows

  2026-06-26

  L-Phenylephrine enables highly selective modeling of adrenergic α1A receptor signaling, unlocking robust cardiac and neural research workflows. This article details experimental protocols, troubleshooting strategies, and key findings that set L-Phenylephrine apart as an advanced tool for dissecting vasoconstrictor and gene regulatory mechanisms.

• Short-Scale Break-Induced DNA Replication in Mouse Oocytes

  2026-06-26

  This study uncovers a unique form of short-scale break-induced replication (ssBIR) triggered by double-strand breaks in fully grown mouse oocytes, revealing mechanisms of DNA damage amplification distinct from those in growing oocytes. The findings offer mechanistic insights into oocyte genome stability and highlight how chemical inhibitors—including ddATP—modulate DNA repair dynamics.

• Mouse Tissue Lysis Kit (K1038): Protocol and Workflow Guide

  2026-06-25

  The Mouse Tissue Lysis Kit (K1038) is designed to rapidly lyse mouse tissues, enabling direct use of genomic DNA in PCR-based genotyping assays. It streamlines molecular biology workflows by eliminating traditional extraction and purification steps. This kit is intended solely for research use and is not suitable for clinical or diagnostic applications.

• YM 58483 (BTP2): Advanced SOCE Blockade for Fibrosis and Imm

  2026-06-25

  Explore how YM 58483 (BTP2), a potent SOCE inhibitor, enables precise modulation of calcium signaling in fibrosis and immune research. This article uniquely examines its assay impact, protocol optimization, and translational potential.

• Anp32e Drives Renal Fibrosis via TGF-β1/Smad3: Mechanistic I

  2026-06-24

  This study reveals that Anp32e significantly contributes to renal interstitial fibrosis by upregulating fibrosis-related proteins through activation of the TGF-β1/Smad3 signaling pathway. The findings provide mechanistic clarity on Anp32e’s role in chronic kidney disease progression and underscore the value of TGF-β pathway inhibition as a research approach.

• Cholesterol Impedes Lipid Nanoparticle Trafficking in Cells

  2026-06-23

  This study uncovers how elevated cholesterol content in lipid nanoparticles (LNPs) impairs their intracellular trafficking by promoting entrapment in peripheral early endosomes, ultimately reducing the efficiency of nucleic acid delivery. The findings emphasize the need to optimize LNP composition beyond cationic lipid content for improved endosomal escape and delivery performance.

• Isolation and Pathogenesis of Chlamydia felis in Feline URTD

  2026-06-23

  This study systematically isolates and characterizes Chlamydia felis from domestic cats, demonstrating its significant role in feline upper respiratory tract disease (URTD) and establishing a comprehensive animal model. The findings clarify C. felis transmission, tissue tropism, and pathogenesis, offering new avenues for vaccine and therapeutic evaluation.

• Primidone (SKU B2120): Reliable RIPK1 & TRPM3 Inhibition in

  2026-06-22

  This article provides a scenario-driven, evidence-based guide for deploying Primidone (SKU B2120) in cell viability and neurodegenerative disease assays. Integrating quantitative data and real-world lab challenges, it demonstrates how APExBIO's Primidone ensures reproducible RIPK1 and TRPM3 inhibition, optimizing workflows for ALS and related disease models.

• Lactobacillus gasseri ATCC33323 Modulates E-cadherin to Amel

  2026-06-22

  This study demonstrates that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice through NR1I3-mediated upregulation of E-cadherin, thereby strengthening the intestinal mucosal barrier. The findings clarify a novel probiotic mechanism with potential translational relevance for inflammatory bowel disease therapy.

• Octenidine Dihydrochloride: Mechanistic Insights for Antisep

  2026-06-21

  Explore advanced, mechanistic perspectives on Octenidine dihydrochloride as a research-grade antiseptic. This article offers deep analysis of its molecular action, scientific utility, and unique value for laboratory assay design.

• LY2228820: Potent p38 MAP Kinase Inhibitor for Research Use

  2026-06-20

  LY2228820 is a highly selective, ATP-competitive p38 MAP kinase inhibitor with nanomolar potency against p38α and p38β isoforms. Its dual mechanism not only blocks kinase activity but also accelerates dephosphorylation, supporting anti-inflammatory and cancer research. This article provides a dense, citation-backed dossier for experimental and translational scientists.

• Amikacin Disulfate: Mechanistic Workflows and Resistance Res

  2026-06-19

  Amikacin disulfate, a semisynthetic aminoglycoside antibiotic, is reshaping how researchers dissect bacterial protein synthesis and explore resistance mechanisms. Advanced protein–drug complex studies, enabled by innovative multimodal approaches, now offer actionable troubleshooting and workflow optimization that set this compound apart.

• GLP-1 (9-36) Amide: Precision Antagonism in Metabolic Resear

  2026-06-19

  Explore the unique role of GLP-1 (9-36) amide as a glucagon-like peptide-1 receptor antagonist in advanced metabolic regulation studies. This article reveals new assay strategies and critical interpretive insights for diabetes research.

• Chloroquine Diphosphate in AML: Linking Autophagy Modulation

  2026-06-18

  Explore how Chloroquine Diphosphate modulates autophagy and cell cycle arrest to sensitize acute myeloid leukemia (AML) cells to ferroptosis, bridging advanced cancer research with translational applications. Uncover unique assay and workflow insights grounded in recent lipid metabolism discoveries.

• LG 101506: RXR Modulator for Nuclear Receptor Signaling Stud

  2026-06-18

  LG 101506 is a synthetic RXR modulator with high purity, enabling precise investigation of RXR signaling pathways in cancer and metabolic disorders. Its well-characterized solubility, stability, and molecular parameters make it a benchmark tool for nuclear receptor research. This article clarifies LG 101506's application boundaries and protocol integration, while contrasting recent findings in immune checkpoint regulation.

15710 records 1/1048 page Next 12345 下5页 Last page